Representative(s): Sarah Donner Heidi Litwin Kurt Landwehr Rich Wardrop Dharmesh Bavda Deciphera Pharmaceuticals
| Deciphera Pharmaceuticals, a commercial biopharmaceutical company, is decoding cancer at the molecular level by leveraging its proprietary platform to develop a diverse pipeline of drug candidates designed to improve outcomes for patients. The Company announced its first FDA-approved medicine in May 2020. Visit our product website at https://qinlockhcp.com/ for more information. Qinlock (ripretinib) Product Website Qinlock Core Claims Qinlock Management Brochure Qinlock (ripretinib) Package Insert
| Virtual Drop InMarch 6th Click here to join the meeting Meeting ID: 912 8184 4144 |